Literature DB >> 18163190

Applicability of the use of charcoal for the evaluation of intestinal motility in a murine model of Trypanosoma cruzi infection.

Gabriel Melo de Oliveira1, Monica de Melo Medeiros, Wanderson da Silva Batista, Renata Santana, Tania C Araújo-Jorge, Andréa Pereira de Souza.   

Abstract

Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a serious public health problem in Latin America. In relation to digestive problems, 4.5% of patients show mega syndromes (megacolon) in the chronic phase. In this article, we evaluated intestinal motility at the acute phase of T. cruzi infection through charcoal ingestion in adult mice. After infection, Swiss mice were administered an aqueous suspension of charcoal in water by gavage. Decrease in intestinal motility was determined by increased time of appearance of charcoal in the feces. The uninfected group showed a mean time of charcoal elimination of 109.0 +/- 14.6 min throughout the assay. On the other hand, infected mice presented a significant increase in charcoal defecation time during infection. At 15 days postinfection, infected mice showed a significant increase in charcoal defecation time, 310.2 +/- 67.4 min when compared to the uninfected group, which presented 97.8 +/- 31.8 min, indicating that the T. cruzi infection interferes with intestinal motility. Our results demonstrate that the use of charcoal is an ethical and efficient procedure to evaluate the intestinal motility in the murine model of T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163190     DOI: 10.1007/s00436-007-0829-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  12 in total

1.  A deficiency of interstitial cells of Cajal in Chagasic megacolon.

Authors:  R Hagger; C Finlayson; F Kahn; R De Oliveira; L Chimelli; D Kumar
Journal:  J Auton Nerv Syst       Date:  2000-04-12

2.  Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis.

Authors:  S J Adad; C G Cançado; R M Etchebehere; V P Teixeira; U A Gomes; E Chapadeiro; E R Lopes
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

3.  Protocol to refine intestinal motility test in mice.

Authors:  Hérida Regina Nunes Marona; Maria Beatriz Bastos Lucchesi
Journal:  Lab Anim       Date:  2004-07       Impact factor: 2.471

4.  Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.

Authors:  Bianca P Olivieri; Andréa P de Souza; Vinícius Cotta-de-Almeida; Solange L de Castro; Tania Araújo-Jorge
Journal:  Exp Parasitol       Date:  2006-04-18       Impact factor: 2.011

5.  Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells.

Authors:  Alexandre Barcelos Morais da Silveira; Elenice M Lemos; Sheila J Adad; Rodrigo Correa-Oliveira; John B Furness; Débora D'Avila Reis
Journal:  Hum Pathol       Date:  2007-05-08       Impact factor: 3.466

6.  Trypanosoma cruzi: preliminary investigation of NADH-positive and somatostatin-immunoreactive neurons in the myenteric plexus of the mouse colon during the infection.

Authors:  L B M Maifrino; S O N Amaral; I Watanabe; E A Liberti; R R De Souza
Journal:  Exp Parasitol       Date:  2005-10-03       Impact factor: 2.011

Review 7.  Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis.

Authors:  F Köberle
Journal:  Adv Parasitol       Date:  1968       Impact factor: 3.870

Review 8.  Chagas disease.

Authors:  A R L Teixeira; N Nitz; M C Guimaro; C Gomes; C A Santos-Buch
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

9.  Intestinal transit and opaque enema study in chagasic mice.

Authors:  T Mori; H S Yoon; F H Iizuka; J M Myung; H R Sato; M F Silva; M Okumura
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1995 Jan-Feb

10.  Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice.

Authors:  Andréa P de Souza; Gabriel Melo de Oliveira; Jean Nève; Jean Vanderpas; Claude Pirmez; Solange L de Castro; Tania C Araújo-Jorge; Maria Teresa Rivera
Journal:  Exp Parasitol       Date:  2002-08       Impact factor: 2.011

View more
  12 in total

1.  Trypanosoma cruzi infection: do distinct populations cause intestinal motility alteration?

Authors:  Monica de Melo Medeiros; Tania C Araújo-Jorge; Wanderson S Batista; Tshaca Mahatma Oara Alves da Silva; Andréa Pereira de Souza
Journal:  Parasitol Res       Date:  2010-05-08       Impact factor: 2.289

2.  Advances in imaging of animal models of Chagas disease.

Authors:  Linda A Jelicks; Herbert B Tanowitz
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

3.  Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study.

Authors:  Cauê B Scarim; Cleverton R de Andrade; João A da Rosa; Jean L Dos Santos; Chung M Chin
Journal:  Int J Exp Pathol       Date:  2018-10-15       Impact factor: 1.925

4.  The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection.

Authors:  Andréa Pereira de Souza; Ryan Sieberg; Hua Li; Hannah R Cahill; Dazhi Zhao; Tania C Araújo-Jorge; Herbert B Tanowitz; Linda A Jelicks
Journal:  Parasitol Res       Date:  2010-02-27       Impact factor: 2.289

5.  A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase.

Authors:  Lars Ny; Hua Li; Shankar Mukherjee; Katarina Persson; Bo Holmqvist; Dazhi Zhao; Vitaliy Shtutin; Huan Huang; Louis M Weiss; Fabiana S Machado; Stephen M Factor; John Chan; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

6.  Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi.

Authors:  Arturo Silvero-Isidre; Sergio Morínigo-Guayuán; Aaron Meza-Ojeda; Marcelo Mongelós-Cardozo; Claudia Centurión-Wenninger; Susy Figueredo-Thiel; Diego F Sanchez; Nidia Acosta
Journal:  Parasitol Res       Date:  2017-12-01       Impact factor: 2.289

7.  Treatment with low doses of aspirin during chronic phase of experimental Chagas' disease increases oesophageal nitrergic neuronal subpopulation in mice.

Authors:  Cristina Lorena Massocatto; Neide Martins Moreira; Eliane Muniz; Silvana Marques de Araújo; Phileno Pinge-Filho; Robson Marcelo Rossi; Eduardo José de Almeida Araújo; Débora de Mello Gonçales Sant'ana
Journal:  Int J Exp Pathol       Date:  2018-01-19       Impact factor: 1.925

Review 8.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

9.  Enteric Neuronal Damage, Intramuscular Denervation and Smooth Muscle Phenotype Changes as Mechanisms of Chagasic Megacolon: Evidence from a Long-Term Murine Model of Trypanosoma cruzi Infection.

Authors:  Camila França Campos; Silvia Dantas Cangussú; Ana Luiza Cassin Duz; Christiane Teixeira Cartelle; Maria de Lourdes Noviello; Vanja Maria Veloso; Maria Terezinha Bahia; Camila Megale Almeida-Leite; Rosa Maria Esteves Arantes
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

Review 10.  Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy.

Authors:  Santiago J Martinez; Patricia S Romano; David M Engman
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 6.073

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.